NCT07073599

Brief Summary

The aim of this study is to raise awareness among midwifery students, who are a part of the female population and a professional group that plays a critical role in the early diagnosis of these types of cancer, which are of critical importance for women's health, through an active education method such as drama.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 10, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 18, 2025

Completed
14 days until next milestone

Study Start

First participant enrolled

August 1, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

July 18, 2025

Status Verified

July 1, 2025

Enrollment Period

3 months

First QC Date

July 10, 2025

Last Update Submit

July 10, 2025

Conditions

Keywords

Creative dramaBreast and gynecological cancersMidwifery studentsAwareness

Outcome Measures

Primary Outcomes (3)

  • Personel Information Form

    The researcher will prepare a form based on literature information and will question the students' sociodemographic characteristics.

    Baseline

  • Gynecological Cancers Awareness Scale

    To assess women's knowledge levels about gynecological cancers, Dal and Ertem developed the Gynecological Cancer Awareness Scale (GCAAS) in 2017. The scale consists of 41 questions and four subscales. 10. The scale can only be applied to women. The Cronbach's alpha value of the scale is 0.944. Questions 20-41 of the scale determine "Awareness of Routine Check-up and Perception of Serious Illness in Gynecological Cancers," and the Cronbach's alpha value of this subscale is 0.979. Questions three through 11 of the scale determine "Awareness of Gynecological Cancer Risks," and the Cronbach's alpha value of this subscale is 0.843. Questions 14-19 of the scale determine "Awareness of Prevention of Gynecological Cancers," and the Cronbach's alpha value is 0.778. The first and second questions of the scale, as well as the 12th and 13th questions, determine "Early Diagnosis and Information Awareness in Gynecological Cancers," and the Cronbach's Alpha value is 0.708.

    Baseline and up to 4 weeks

  • Breast Cancer Awareness Scale

    The scale was developed by Rakkapao et al. (2016) for the early detection and prevention of breast cancer. It is easy to use and was designed as a self-report tool that allows researchers and practitioners to better understand women's breast cancer awareness levels. The original scale consists of five factors and 35 items. Adapted to our language by Altuntuğ et al. in 2021, the scale obtained a five-factor structure with 29 items. The subdimensions of the scale were found to have good internal consistency. The Cronbach's alpha internal consistency coefficients for the subdimensions of the scale were 0.87 for Knowledge of Risk Factors, 0.88 for Knowledge of Signs and Symptoms, 0.81 for Breast Cancer Prevention Attitudes, 0.78 for Barriers to Breast Screening, and 0.61 for Health Behavior Related to Breast Cancer Awareness.

    Baseline and up to 4 weeks

Study Arms (2)

Control Group

NO INTERVENTION

The control group will receive routine training and no action will be taken.

Experimental Group

EXPERIMENTAL

Students in the intervention group will be given a creative drama session. This will evaluate the impact of creative drama training on breast and gynecological cancer awareness.

Other: Creative Drama Education

Interventions

This study is a pre-test/post-test controlled experimental design aimed at evaluating the effectiveness of creative drama education on awareness of breast and gynecological cancers. Students in the intervention group will receive creative drama-based training structured and implemented by the researcher. This training is designed to increase awareness of breast and gynecological cancers. The effectiveness of the training will be assessed by comparing participants' awareness levels before and after the intervention. For this purpose, the following data collection tools will be used: Personal Information Form Breast Cancer Awareness Scale Gynecological Cancers Awareness Scale The impact of the creative drama education on the awareness levels of students in the intervention group regarding breast and gynecological cancers will be evaluated through statistical analysis.

Experimental Group

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Being between the ages of 18-35,
  • Not having any health problems,
  • Agreeing to participate in the study,

You may not qualify if:

  • Students who are under 18 or over 35 years old.
  • Students who do not voluntarily agree to participate in the study will not be included in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ataturk University Faculty of Health Sciences

Erzurum, Center, 25000, Turkey (Türkiye)

Location

Related Publications (1)

  • Erci B, Karabulut N. Appraising the self-assessed support needs of Turkish women with breast cancer. Eur J Cancer Care (Engl). 2007 Mar;16(2):137-43. doi: 10.1111/j.1365-2354.2006.00721.x.

    PMID: 17371422BACKGROUND

Related Links

Study Officials

  • Zülbiye DEMİR BARBAK, 1

    Ataturk University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Zülbiye DEMİR BARBAK, 1

CONTACT

Sultan Esra SAYAR, Lecturer

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

July 10, 2025

First Posted

July 18, 2025

Study Start

August 1, 2025

Primary Completion

November 1, 2025

Study Completion

February 1, 2026

Last Updated

July 18, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations